Classification of Medicines Pursuant to section 106 (1) of the Medicines Act 1981, I, G. Grew, Chief Advisor, Regulation and Safety (acting), acting under delegated authority, hereby declare the following: The medicines listed in Schedule 1 to this notice are classified as prescription medicines. Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources. Unless specific reference is made otherwise, every reference applies also to medicines that are: (a) Preparations and admixtures containing any proportion of any substance listed in the notice; (b) Salts and esters of any substance listed in the notice; (c) Preparations or extracts of biological materials listed in the notice; (d) Salts or oxides of elements listed in the notice. Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise. Schedule 1 Prescription Medicines alatrofloxacin androgenic and anabolic steroidal agents antibiotic substances; except when specified elsewhere in the Schedule antisera; for parenteral use arsenic clopidrogel dinitrocresols dinitronaphthols dinitrothymols eprosartan estropipate gemcitabine hypothalamic releasing factors ion exchange resins; except when specified elsewhere in the Schedule monoclonal antibodies; except in pregnancy test kits prostaglandins rituximab rizatriptan sex hormones and all substances having sex hormone activity silicones; for parenteral use temozolomide tolterodine toxoids; for parenteral use trovafloxacin Medicines for General Sale Please note that the following medicines are no longer classified as prescription medicines, restricted medicines or pharmacy-only medicines. As such, they are now available for general sale: amorolfine; in topical preparations for tinea pedis only bifonazole; in topical preparations for tinea pedis only ciclopirox; in topical preparations for tinea pedis only clotrimazole; in topical preparations for tinea pedis only econazole; in topical preparations for tinea pedis only hexamidine; in topical preparations for tinea pedis only ketoconazole; in topical preparations for tinea pedis only miconazole; in topical preparations for tinea pedis only nystatin; in topical preparations for tinea pedis only oxiconazole; in topical preparations for tinea pedis only paracetamol; in powdered form in sachets containing 1000 milligrams or less and in packs containing not more than 10 grams terbinafine; in topical preparations for tinea pedis only tioconazole; in topical preparations for tinea pedis only. Dated this 3rd day of March 1999. G. GREW, Chief Advisor, Regulation and Safety (Acting).